|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,897.00 GBX | +1.58% |
|
-4.86% | +7.50% |
| 26/06 | FTSE 100 falls as OpenAI delay report knocks tech | AN |
| 26/06 | WINNERS & LOSERS: British American Tobacco announces buyback | AN |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 188.96Cr | 208.93Cr | 169.45Cr | 162.81Cr | 169.94Cr | |||||
Total Revenues | 188.96Cr | 208.93Cr | 169.45Cr | 162.81Cr | 169.94Cr | |||||
Cost of Goods Sold, Total | 95Cr | 110.37Cr | 96Cr | 89Cr | 95Cr | |||||
Gross Profit | 94Cr | 99Cr | 73Cr | 73Cr | 75Cr | |||||
Selling General & Admin Expenses, Total | 50Cr | 54Cr | 48Cr | 50Cr | 63Cr | |||||
Other Operating Expenses, Total | 50Cr | 54Cr | 48Cr | 50Cr | 63Cr | |||||
Operating Income | 44Cr | 45Cr | 25Cr | 23Cr | 12Cr | |||||
Interest Expense, Total | -2.21Cr | -2.41Cr | -2.6Cr | -3.1Cr | -2.83Cr | |||||
Interest And Investment Income | 15L | 27L | 94L | 69L | 30L | |||||
Net Interest Expenses | -2.06Cr | -2.14Cr | -1.66Cr | -2.41Cr | -2.53Cr | |||||
Other Non Operating Income (Expenses) | -25L | - | - | - | - | |||||
EBT, Excl. Unusual Items | 42Cr | 43Cr | 24Cr | 21Cr | 9.1Cr | |||||
Merger & Related Restructuring Charges | -15L | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | 36Cr | - | - | - | |||||
Other Unusual Items | -33L | -17L | - | - | - | |||||
EBT, Incl. Unusual Items | 41Cr | 78Cr | 24Cr | 21Cr | 9.1Cr | |||||
Income Tax Expense | 8.87Cr | 13Cr | 6.42Cr | 4.82Cr | 2.63Cr | |||||
Earnings From Continuing Operations | 32Cr | 65Cr | 17Cr | 16Cr | 6.47Cr | |||||
Net Income to Company | 32Cr | 65Cr | 17Cr | 16Cr | 6.47Cr | |||||
Minority Interest | -20L | -40L | -11L | -11L | -27L | |||||
Net Income - (IS) | 32Cr | 65Cr | 17Cr | 16Cr | 6.2Cr | |||||
Preferred Dividend and Other Adjustments | - | - | - | - | - | |||||
Net Income to Common Incl Extra Items | 32Cr | 65Cr | 17Cr | 16Cr | 6.2Cr | |||||
Net Income to Common Excl. Extra Items | 32Cr | 65Cr | 17Cr | 16Cr | 6.2Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 2.3 | 4.66 | 1.22 | 1.14 | 0.44 | |||||
Basic EPS - Continuing Operations | 2.3 | 4.66 | 1.22 | 1.14 | 0.44 | |||||
Basic Weighted Average Shares Outstanding | 14Cr | 14Cr | 14Cr | 14Cr | 14Cr | |||||
Net EPS - Diluted | 2.3 | 4.65 | 1.22 | 1.14 | 0.44 | |||||
Diluted EPS - Continuing Operations | 2.3 | 4.65 | 1.22 | 1.14 | 0.44 | |||||
Diluted Weighted Average Shares Outstanding | 14Cr | 14Cr | 14Cr | 14Cr | 14Cr | |||||
Normalized Basic EPS | 1.85 | 1.88 | 1.05 | 0.92 | 0.39 | |||||
Normalized Diluted EPS | 1.85 | 1.88 | 1.05 | 0.92 | 0.39 | |||||
Dividend Per Share | 1 | 1.08 | 1.09 | 1.1 | 1.11 | |||||
Payout Ratio | 41.3 | 22.24 | 88.13 | 96.03 | 249.84 | |||||
American Depositary Receipts Ratio (ADR) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 54Cr | 55Cr | 36Cr | 35Cr | 23Cr | |||||
EBITA | 47Cr | 48Cr | 29Cr | 27Cr | 15Cr | |||||
EBIT | 44Cr | 45Cr | 25Cr | 23Cr | 12Cr | |||||
EBITDAR | 54Cr | 55Cr | 36Cr | 35Cr | 24Cr | |||||
Effective Tax Rate - (Ratio) | 21.56 | 16.24 | 27.17 | 23.2 | 28.9 | |||||
Current Domestic Taxes | 1.15Cr | 2.81Cr | -15L | -8L | 18L | |||||
Current Foreign Taxes | 9.5Cr | 10Cr | 6.21Cr | 6.2Cr | 5.52Cr | |||||
Total Current Taxes | 11Cr | 13Cr | 6.06Cr | 6.12Cr | 5.7Cr | |||||
Total Deferred Taxes | -1.78Cr | -14L | 36L | -1.3Cr | -3.07Cr | |||||
Normalized Net Income | 26Cr | 26Cr | 15Cr | 13Cr | 5.42Cr | |||||
Interest Capitalized | - | - | - | - | - | |||||
Interest on Long-Term Debt | 1.99Cr | 1.99Cr | 2.28Cr | 2.86Cr | 2.68Cr | |||||
Non-Cash Pension Expense | 1.35Cr | 93L | 39L | 48L | -25L | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 9.3Cr | 10Cr | 7.72Cr | 7.92Cr | 8.07Cr | |||||
General and Administrative Expenses | 41Cr | - | 41Cr | 43Cr | 55Cr | |||||
Research And Development Expense From Footnotes | 7.45Cr | 8.18Cr | 8.03Cr | 8.14Cr | 7.62Cr | |||||
Net Rental Expense, Total | 14L | 10L | 12L | 12L | 13L | |||||
Imputed Operating Lease Interest Expense | 3L | 2L | 4L | 4L | 4L | |||||
Imputed Operating Lease Depreciation | 11.31L | 8L | 8L | 8L | 9L | |||||
Stock-Based Comp., Other (Total) | 4.13Cr | -1.1Cr | -42L | 50L | 50L | |||||
Total Stock-Based Compensation | 4.13Cr | -1.1Cr | -42L | 50L | 50L |
- Stock Market
- Stocks
- CRDA Stock
- Financials Croda International Plc
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















